Prepared remarks
Good day, everyone, and thank you for standing by. Welcome to the SQM Second Quarter 2026 Conference Call. Please be advised that today's conference is being recorded. Now it's my pleasure to hand the conference to Megan Suitor with Investor Relations. Please proceed.
Good day, and thank you for joining SQM's earnings conference call for the second quarter of 2026. This call is being recorded and webcast live. Our earnings press release and the accompanying results presentation are available on our website where you can also find a link to the webcast. Today's participants include Mr. Ricardo Ramos, Chief Executive Officer; Mr. Gerardo Illanes, Chief Financial Officer; Mr. Carlos Diaz, CEO of Novandino; Mr. Pablo Altimiras, CEO of the Iodine and Plant Nutrition division; and Mr. Mark Fones, CEO of the International Lithium division. Also joining us today are members of our commercial and business intelligence team. Mr. Felipe Smith, Commercial Vice President of Novandino; Mr. Pablo Hernandez, Vice President of Strategy and Development of Novandino; Mr. Juan Pablo Bellolio, Commercial Vice President for Plant Nutrition & Specialty Products; Mr. Alvaro Araya, CFO of the International Lithium Division; Mr. Andres Fontannaz, Commercial Vice President of the International Lithium Division; and Mr. Max Vial, Head of Studies of the International Lithium Division. Before we begin, please note that statements made during this call regarding our business outlook, future economic performance, anticipated profitability, revenues, expenses and other financial items, along with expected cost synergies and product or service line growth, are considered forward-looking statements under U.S. federal securities laws. These statements are not historical facts and are subject to risks and uncertainties that could cause actual results to differ materially. We assume no obligation to update these statements, except as required by law. For a full discussion of forward-looking statements, please refer to our earnings press release and presentation. With that, I will now turn the call over to our Chief Executive Officer, Mr. Ricardo Ramos.
Thank you. Good morning, and thank you for joining us today. I'm pleased to report SQM's second quarter results, which reflect a strong performance across our main business lines. I would like to start by highlighting an important milestone for our lithium operations in Chile. In July, Novandino Litio, our association with Codelco, submitted the environmental and technical documentation for the Salar Futuro project to the authorities. Salar Futuro represents the next stage in the transformation of our operations in the Salar de Atacama, subject to the required approvals. The project contemplates approximately $3 billion of investment over 7 years and is designed to increase production while significantly reducing the environmental footprint of our operations. I would also like to highlight the contribution that our operations made to Chile. During the first half of this year, SQM and its subsidiaries accrued more than $1.6 billion in payments to the Chilean government including taxes, contributions to local governments and payments to CORFO. Moving to the lithium market. We achieved record quarterly sales volumes of more than 84,000 metric tons of lithium carbonate equivalent from our operations in Chile through Novandino Litio and in Australia through Covalent Lithium. As anticipated in our previous earnings report, lithium prices increased during the second quarter, supported by a stronger-than-expected market demand. We now expect global lithium demand to exceed 2.1 million metric tons in 2026. We continue to expand our production capabilities in both Chile and Australia. In Chile, we expect Novandino Litio to produce between 280,000 and 290,000 metric tons of lithium carbonate equivalent this year and to have approximately 300,000 metric tons of production capacity by next year. In Australia, together with our partner Wesfarmers, we recently announced the expansion of the Mount Holland mine and concentrator, which is expected to double spodumene concentrate production capacity to approximately 350,000 metric tons per year corresponding to SQM shares of the project with first production expected in 2030. These investments reflect our long-term view of the lithium market and our confidence in the fundamentals of the energy transition. Moving to iodine, we once again delivered good results, supported by robust market demand and favorable pricing. We expect demand to remain robust. Our seawater pipeline is currently in its commissioning phase and will provide additional flexibility to optimize our production and respond to market conditions. We are now producing iodine from our four different operations, and we expect total iodine production to reach approximately 15,500 metric tons this year. Turning to specialty plant nutrition, we delivered another strong quarter supported by higher sales prices and volumes. We continue to expect full year sales volumes to increase by approximately 10% compared to 2025. Market conditions have benefited from supply constraints in certain markets, and we expect this condition to gradually normalize towards the end of the year. Finally, we have updated our capital expenditure outlook; we now include 2028, and we expect approximately total capital expenditures of approximately $3 billion over the three-year 2026-2028 period. This investment is mainly focused on supporting future growth and enhancing the competitiveness of our operations through lower production costs. Overall, we are encouraged by the performance delivered during the first half of the year and remain focused on executing our growth plans and creating long-term value for our shareholders. With that, I will turn the call and we can go, operator, to the Q&A. Thank you.
Questions and answers
Our first question is from Joel Jackson with BMO Capital Markets.
I'm going to ask a couple of questions, one by one. Can you talk about Q3 for a second. If I look at Q3 for the lithium segment, you're guiding to prices about flat, volumes seems like about flat. And then cost, I had a question about because costs stepped down a lot in Q2. Should we expect Q3 lithium earnings gross margin to be about the same as Q2?
Joel, this is Felipe. I will comment about the Novandino part, of course. So yes, indeed, we had a very good second quarter. We're very enthusiastic about how the market is doing. Regarding Q3, first of all, in terms of sales volume, we expect Q3 2026 to remain strong, in line with Q2. And in terms of the price, I would say that the average price based on the indexes, because you know that our contracts are all based on indices and indices are well known. Based on that, we believe that the price of Q3 should be more or less in line with what we saw as the average of the first semester. But again, nobody can predict where the indices are going. It's a very volatile market today, still difficult to predict prices for too long.
Joel, this is Carlos Diaz. Regarding the cost, mainly, we have been working hard in the last year on a continuous efficiency and improvement process and that, together with economies of scale as we have been increasing the production level, has allowed us to constantly make cost improvements. So in Q3, we expect a similar cost level to what we already achieved in Q2. But for the early part of 2026, costs should be lower compared with last year.
I want to ask about price realizations between Novandino and International Australia. I understand some of the math that works with toll and things like that. But the premium of Chile, the Novandino average selling price is really expanding, the premium is really widening versus international. Should we expect a catch-up in Q3? Like even if Novandino average selling price is about the same in Q3, should we not expect international selling price to catch up to go up and the gap to reduce?
Joel, this is Andres Fontannaz from the international lithium division. Most of our sales are based on spodumene concentrate. So in order to compare, you need to add some conversion costs and also take into consideration the conversion yield. So that's where the main difference is. And at the end, what matters the most is that we are also following the market. These shipments are discrete because not every month we have sales. All these shipments are following market conditions at the moment of shipment.
That's the point of my question, though. The spodumene average selling price by our own numbers increased by $600 a ton from Q1 to Q2. Spodumene went up $600 a ton price Q1 to Q2, but your average LCE equivalent international selling price barely went up. That's what I'm confused about.
Yes. Well, as we commented before, our reported prices are affected by the timing of the shipments. Again, not every month we are having shipments. As I said, in the coming quarters, you will see this better reflected in our price reporting.
I'll ask one more question to be greedy. So you raised your lithium demand expectations for the full year by 200,000 tons. I imagine you're going to tell me it's on the demand side at all from energy storage. Where is the extra 200,000 tons of supply coming from? Is that restarts in Australia? Is that Africa? Is that lepidolite in China? Where is the extra 200,000 tons of supply coming this year to meet the growing demand?
Joel, this is Pablo Hernandez speaking. So of course, these are just our estimations. We cannot predict what's actually happening fully in the market. But we believe there is some increase of supply mainly coming from China, both from spodumene and brine, but also some ramp-up projects in Africa and Argentina. And of course, as you've heard, because of the current price scenario, there are some restarts in Australia also coming into the market.
One moment for our next question that comes from Isabella Simonato with Bank of America.
Do you hear me?
Yes, please proceed.
I have two questions. First is still on the lithium market. I believe you are ramping up production in Novandino faster than initially expected when the deal was signed. So I wonder if you could update us on that; you mentioned about 300,000 tons next year. But beyond that, when the new concession comes into place, what could be feasible production levels, especially once Salar Futuro is operating, in terms of annual production? That would be my first question. My second question is on the iodine market. It was a pretty good quarter in terms of volumes as well as prices. You mentioned some slowdown in sales as more supply is coming. Can you elaborate a little bit on where this supply from third parties is coming from and what that could mean in terms of prices for the second half? Thank you.
Isabella, this is Carlos Diaz, again. Well, this year, as our CEO said before, we expect to produce around 280,000 to 290,000 metric tons. Looking ahead, growth will initially be moderated as we continue reducing the brine extraction. Specifically for next year, we expect production close to 300,000. And for the coming years, we are still studying different initiatives in order to keep and to increase production a little bit. But you have to take into account that we are reducing brine extraction. So it's an exercise we are not ready to finalize yet. We will be able to share more in a future conference call.
Pablo Altimiras speaking. Regarding your question about iodine and the new supply, again, this is our estimation, but we believe that the main supply could arrive from projects here in Chile. We see a particular new project that is coming. It's a project of unknown scale. With respect to the amount of product that will come into the market, we actually don't know, but we expect that they will provide more product. That's the reason why we believe that our sales volume this year will be similar to what we saw last year. Of course, if something different happens with the supply, we could potentially see more sales in our case, but everything will depend on supply and demand.
But just a final comment on the iodine. Can you quantify a little bit what this new project in Chile means in terms of volumes, and again, any significant disruption in terms of supply-demand and ultimately to prices?
What is important to remain is that we have seen good demand. Our demand forecast for this year is that growth will be around 3%. So we expect that the new capacity that will come into the market will compensate that growth, but we don't see more than that.
Our next question comes from Emerson Vieira with Goldman Sachs.
A couple of questions here. First, can you please break down the expected production capacity increase to 300,000 tons in 2027? I mean how much is coming from Chile given that you're converting the hydroxide plant? And how much is coming from tolling contracts? That's the first question. I have some follow-ups.
Emerson, this is Carlos Diaz speaking. First of all, all of our production is coming from the Salar de Atacama in two different ways. One is lithium chloride that is refined in Chile and lithium sulfate where refined in China. So I think what I said before, this year we expect 280,000 to 290,000, and for next year, 300,000. Of those, we estimate now about 80,000 of those is going to be from lithium sulfate and the other 220,000 from our Antofagasta chemical plant. You asked for the carbonate versus hydroxide production?
Carbonate.
On carbonate, we don't see more than 20,000 or 30,000 of those total that means 10% of that production will be hydroxide and the remainder, obviously, carbonate.
Okay. And just on Mount Holland very quickly. You guys recently approved the expansion, right, on the mine and the concentrator. So just wondering about a potential expansion in the refinery, are you guys planning maybe to do this just after the expansion is concluded? How are you thinking about the mix between hydroxide and spodumene sales going in 2027 and later on, please?
This is Mark Fones here. Thanks for your question. Regarding the expansion of Mount Holland, we're very proud of the decision to expand the mine and concentrator. Regarding the refinery, we still remain open to that decision. We have not yet come to a conclusion or a decision there yet. This will be continued to be analyzed by Covalent and our partner Wesfarmers. It will also depend on reaching our ramp-up at full extent by the second semester next year. Regarding the balance for next year in terms of sales and production, we expect next year to have higher lithium hydroxide production than this year, for sure, based on the same ramp-up curve. Therefore, our sales of direct spodumene concentrate should probably be lower than this year.
One moment for our next question, please. It comes from Lucas Ferreira with JPMorgan.
My first question is a follow-up on the sulfate production, especially in regards to the tolling processing in China. This production surprised me a lot. I never thought you guys could ramp up this tolling and find too much capacity in a short period of time. So my question is regarding these tolling contracts. I just wanted to understand how long they are, and if you guys see any risk over the next few years that you have to give some away or find new partners for this tolling at maybe different costs if these fees are fixed and predictable. Just to understand the operational risk of running, if not mistaken, something around 50,000 tons of sulfate tolling with these third parties. And then my second question is regarding a follow-up on Mount Holland since the expectation is for first production in 2030. This seems to be an extended period of time considering this is a brownfield. Just wondering what are the next big milestones there and the main challenges to bring this capacity online.
This is Carlos Diaz speaking regarding the lithium sulfate production. Yes, we have been increasing production very strongly in the last three or four years. We expect next year to produce in a range of 80,000 to 90,000 LCE equivalent. First of all, I want to remind that we have our own plant in China where we produce close to 24,000 to 25,000. We're expanding and expect to reach around 30,000. The difference we do via tolling with different suppliers that we don't disclose, but we're very happy with the contracts that we have and we expect to continue working with those in the coming year.
This is Mark Fones. Regarding the Mount Holland timeline, you're right, the first product is expected by the first half of 2030. The schedule reflects the normal sequencing for a project of this scale, and we are building the structure to achieve derisked rather than rushed projects. You need to consider also that this is a relevant, not a marginal, brownfield increase. We are doubling the capacity where our operation already exists. The next relevant milestone is the start of the construction of the facility itself, which should happen in mid next year. Construction of a facility of this nature takes between 18 and 24 months. Ahead of that, we need to purchase long-lead items, prepare earthworks and earth movement. After the 18 to 24 months of construction, there's a period of commissioning, which will follow in 2029 to reach our first product at the beginning of 2030. Those are the overall milestones. In terms of opportunities to compress the schedule, yes, there are opportunities. Covalent and our technical teams are actively analyzing those and we will continue to push it forward. But please take into consideration that while this brownfield has relevant opportunities since we're working on an existing operation, it also increases levels of challenges, and we need to always mine safely.
One moment for our next question, that comes from Corinne Blanchard with Deutsche Bank.
Maybe, can we come back to your commentary about the 3Q sales being in line with 2Q. How do we think about it for 4Q because normally 4Q, I think on seasonality is your highest quarter. Do you also expect 4Q to be high 70s to maybe like 80 kilotons each? Or are you expecting a strong 3Q followed maybe by a softer 4Q?
Corrine, this is Felipe. Fourth quarter is so far away now, so I'll try to speak about the long-term future but I only have hopes that we can at least have the volume of the second and third quarter because, as I said before, third quarter we expect to have a similar volume as second quarter. So I expect a minimum in the fourth quarter, but hope that could be more. But again, this is my personal hope.
So that should bring you to 315, 320 kilotons, which is much more than what you have guided, right?
Yes. If you want only the Novandino part, I mean I will speak about the Novandino part as hopefully above 280 and then my colleagues in the international division could comment. Maybe Andres, good luck.
Andres speaking here, we are expecting sales to be around 27,000 to 30,000 tons LCE for the full year.
Okay. That's helpful. Then a bigger picture question because I think some investors are starting to think more longer term. Can you just talk a little bit about what happens after 2030, 2031? I mean we know that Codelco will probably be much more in charge than you guys. But if you can provide a high-level view to frame it for us and how we should think about strategy decisions and CapEx, I think that will be helpful. Thank you.
Ricardo Ramos speaking. Yes, as Felipe said, fourth quarter is a long way away. 2031 is more difficult to predict. But again, I think that we are working very well now in Novandino. The agreement with Codelco has been even better than expected in terms of coordination, working together at the Board level, and cooperation between both companies. That's why we are very positive about that. We already commented in the press release that we started the submission; we did it in July for the Salar Futuro. We're working in engineering to be ready for the investment. That's why I hope in 2031 we would be in the middle of the investment for Salar Futuro. We think it's going to be a great project. We are really committed with Codelco to do so. Everything is included in our long-term projections, all the investment and the work we want to do, and what Carlos is doing today with his team is trying to have a very good expectation about volumes and sales volumes for the future. We will share with you in the next conference call our first view about what we expect for the next year, and we will continue to have a long-term view. We are working very hard and have very good agreements so far, and Codelco is a very good partner.
One moment for our next question, that comes from Ben Isaacson with Scotiabank.
Just two questions for me. Number one is, I think there's a bit of confusion among investors in terms of your recent filing of spending $3 billion at Salar Futuro, and some are drawing the conclusion that it is all going towards increasing capacity by 30,000 tons. And therefore, your CapEx is $100,000 per ton. I think that's wrong. Can you just separate the $3 billion spend from the 30,000 ton increase in capacity? And then my second question is on the lithium market. I understand that battery storage production has been about 1 terawatt hour or around that area, but installations have only been about half of that. So my question is, are we seeing a big inventory build in battery storage, and could we be going into some temporary oversupply over the next 12 to 18 months that could put a cap on lithium demand growth? Or is this just part of the normal cycle and the lag in installations will catch up in 6 to 12 months? Just trying to understand if this is an anomaly or if this growth rate is sustainable?
Ben, it's very important to consider that the Salar Futuro project is not only increasing capacity, it is changing technology. It means we are offering a very good technology in terms of cost, production and environmental footprint. You have to analyze the Salar Futuro project as a whole in terms of having a new beginning of the Salar de Atacama for the next 60 years of operation. That's exactly our vision for the next 30 years of operation. Of course, we expect to have more production. We are working on it, and it will depend on the technical solutions and the final decisions we make. We will disclose our best estimate in the next two years, but the whole Salar Futuro project is not just an idea to increase production capacity. It's much more than that in terms of revamping and creating a new Salar de Atacama for the future.
That makes sense. And then my second question is on the lithium market and battery storage production versus installations. Are we seeing a big inventory build in battery storage that could cause temporary oversupply, or is this a normal lag that will correct in 6 to 12 months?
Pablo Hernandez speaking. I agree with your view on the market. Indeed, we have seen much larger shipments of batteries for BESS than actual deployments of those batteries. So there is some gap there that we are monitoring. We believe most of that gap is related to some larger projects being implemented, which naturally bring longer implementation timelines and some delays from approvals and other processes. So there's a natural delay there. As well, I think there's also some pull-forward of sales from 2027 because of tax rebates that have been removed from the export side in China. Overall, my view for the longer term is that for the following years we might see some slowdown in the pace at which BESS implementation is growing. But of course, BESS will remain a very relevant and strong demand factor for the future.
Ladies and gentlemen, this will conclude our Q&A session and conference for today. We want to thank everyone for participating, and you may now disconnect.